Dako North America, Inc. (Acquired by Agilent Technologies, Inc.) Collaborates On Review Of Immunohistochemistry’s Impact On Prostate Diagnostics

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GLOSTRUP, Denmark, March 5, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and worldwide provider of cancer diagnostics , today announced the release of a new review paper titled " Immunohistochemistry in Prostate Pathology” that illustrates the significant impact immunohistochemistry (IHC) can have on diagnostic prostate pathology.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC